123 related articles for article (PubMed ID: 38752902)
1. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Simader FA; Mohsin M; Ganesananthan S; Nowbar AN; Chotai S; Sen S; Petraco R; Nijjer SS; Sehmi J; Ruparelia N; Dungu JN; Kabir A; Tang K; Gamma R; Davies JR; Kotecha T; Cole GD; Howard JP; Keeble TR; Clesham G; O'Kane PD; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK
J Am Coll Cardiol; 2024 Jul; 84(1):1-12. PubMed ID: 38752902
[TBL] [Abstract][Full Text] [Related]
2. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
Simader FA; Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Chotai S; Bual N; Khokhar A; Gohar A; Lampadakis I; Ganesananthan S; Pathimagaraj RH; Nowbar A; Davies JR; Keeble TR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Spratt JC; Williams R; Nijjer SS; Sen S; Curzen N; Sinha M; Howard JP; Cole G; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK;
J Am Coll Cardiol; 2024 Jul; 84(1):13-24. PubMed ID: 38759906
[TBL] [Abstract][Full Text] [Related]
3. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
[TBL] [Abstract][Full Text] [Related]
4. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Nowbar AN; Simader FA; Davies JR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Gamma R; Clesham G; Williams R; Din J; Nijjer SS; Curzen N; Ruparelia N; Sinha M; Dungu JN; Ganesananthan S; Khamis R; Mughal L; Kinnaird T; Petraco R; Spratt JC; Sen S; Sehmi J; Collier DJ; Sohaib A; Keeble TR; Cole GD; Howard JP; Francis DP; Shun-Shin MJ; Al-Lamee RK;
N Engl J Med; 2023 Dec; 389(25):2319-2330. PubMed ID: 38015442
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R; Thompson D; Dehbi HM; Sen S; Tang K; Davies J; Keeble T; Mielewczik M; Kaprielian R; Malik IS; Nijjer SS; Petraco R; Cook C; Ahmad Y; Howard J; Baker C; Sharp A; Gerber R; Talwar S; Assomull R; Mayet J; Wensel R; Collier D; Shun-Shin M; Thom SA; Davies JE; Francis DP;
Lancet; 2018 Jan; 391(10115):31-40. PubMed ID: 29103656
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
[TBL] [Abstract][Full Text] [Related]
7. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
[TBL] [Abstract][Full Text] [Related]
8. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader FA; Chotai S; Pathimagaraj RH; Mohsin M; Salih A; Wang D; Dixit P; Davies JR; Keeble TR; Cosgrove C; Spratt JC; O'Kane PD; De Silva R; Hill JM; Nijjer SS; Sen S; Petraco R; Mikhail GW; Khamis R; Kotecha T; Harrell FE; Kellman P; Francis DP; Howard JP; Cole GD; Shun-Shin MJ; Al-Lamee RK
Lancet; 2024 Apr; 403(10436):1543-1553. PubMed ID: 38604209
[TBL] [Abstract][Full Text] [Related]
9. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
Al-Lamee RK; Shun-Shin MJ; Howard JP; Nowbar AN; Rajkumar C; Thompson D; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik I; Bual N; Cook C; Ahmad Y; Seligman H; Sharp ASP; Gerber R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom S; Davies JE; Francis DP
Circulation; 2019 Dec; 140(24):1971-1980. PubMed ID: 31707827
[TBL] [Abstract][Full Text] [Related]
10. Long-term improvement of symptoms of angina pectoris after successful revascularization of coronary artery chronic total occlusions.
Miyashita H; Mansikkaniemi L; Sinisalo J; Stewart J; Laine P
Scand Cardiovasc J; 2023 Dec; 57(1):2161621. PubMed ID: 36587829
[No Abstract] [Full Text] [Related]
11. Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease.
Collet C; Collison D; Mizukami T; McCartney P; Sonck J; Ford T; Munhoz D; Berry C; De Bruyne B; Oldroyd K
JACC Cardiovasc Interv; 2022 Dec; 15(24):2506-2518. PubMed ID: 36543445
[TBL] [Abstract][Full Text] [Related]
12. 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial.
Patel MR; Jeremias A; Maehara A; Matsumura M; Zhang Z; Schneider J; Tang K; Talwar S; Marques K; Shammas NW; Gruberg L; Seto A; Samady H; Sharp ASP; Ali ZA; Mintz G; Davies J; Stone GW
JACC Cardiovasc Interv; 2022 Jan; 15(1):52-61. PubMed ID: 34991824
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
Ganesananthan S; Rajkumar CA; Foley M; Thompson D; Nowbar AN; Seligman H; Petraco R; Sen S; Nijjer S; Thom SA; Wensel R; Davies J; Francis D; Shun-Shin M; Howard J; Al-Lamee R
Eur Heart J; 2022 Sep; 43(33):3132-3145. PubMed ID: 35639660
[TBL] [Abstract][Full Text] [Related]
14. A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial.
Nowbar AN; Rajkumar C; Foley M; Ahmed-Jushuf F; Howard JP; Seligman H; Petraco R; Sen S; Nijjer SS; Shun-Shin MJ; Keeble TR; Sohaib A; Collier D; McVeigh P; Harrell FE; Francis DP; Al-Lamee RK
EuroIntervention; 2022 Apr; 17(18):1490-1497. PubMed ID: 35156616
[TBL] [Abstract][Full Text] [Related]
15. Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors.
Collison D; Copt S; Mizukami T; Collet C; McLaren R; Didagelos M; Aetesam-Ur-Rahman M; McCartney P; Ford TJ; Lindsay M; Shaukat A; Rocchiccioli P; Brogan R; Watkins S; McEntegart M; Good R; Robertson K; O'Boyle P; Davie A; Khan A; Hood S; Eteiba H; Berry C; Oldroyd KG
Circ Cardiovasc Interv; 2023 Apr; 16(4):e012511. PubMed ID: 36974680
[TBL] [Abstract][Full Text] [Related]
16. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
Nowbar AN; Francis DP; Al-Lamee RK
Cardiovasc Drugs Ther; 2022 Oct; 36(5):1011-1018. PubMed ID: 34417901
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
